Study Shows Long-Term Benefits of Rituxan

Some lymphoma patients who keep taking Genentech Inc and Biogen Idec’s Rituxan after chemotherapy live 40 percent longer than those who stop taking the drug, Israeli researchers said.
LSE.co.uk